Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Noe

Showing results (81-90 of 111) with videos related to

Pageof 12
Sort By:
Nucleic Acids Research|November 11, 1991
A simple procedure for the preparation of protected 2'-O-methyl or 2'-O-ethyl ribonucleoside-3'-O-phosphoramiditesE Wagner, B Oberhauser, A Holzner, et al.
Nucleic Acids Research|May 25, 1991
2'-O-methyl, 2'-O-ethyl oligoribonucleotides and phosphorothioate oligodeoxyribonucleotides as inhibitors of the in vitro U7 snRNP-dependent mRNA processing eventM Cotten, B Oberhauser, H Brunar, et al.
Plos One|January 28, 2014
Transport rankings of non-steroidal antiinflammatory drugs across blood-brain barrier in vitro modelsIveta Novakova, Eva-Anne Subileau, Stefan Toegel, et al.
Chirality|January 1, 1994
Improved synthesis and pharmacologic activity of the enantiomers of a new benzofurane type antiarrhythmic compoundG Ecker, W Fleischhacker, T Helml, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|June 26, 1999
Evaluation of aminoalkylmethacrylate nanoparticles as colloidal drug carrier systems. Part I: Synthesis of monomers, dependence of the physical properties on the polymerization methodsH P Zobel, A Zimmer, S Atmaca-Abdel Aziz, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|September 8, 1999
Evaluation of aminoalkylmethacrylate nanoparticles as colloidal drug carrier systems. Part II: characterization of antisense oligonucleotides loaded copolymer nanoparticlesH P Zobel, F Stieneker, S Atmaca-Abdel Aziz, et al.
The Journal of Infectious Diseases|March 13, 2015
Proteolytic Cleavage of the Plasmodium falciparum Circumsporozoite Protein Is a Target of Protective AntibodiesDiego A Espinosa, Gabriel M Gutierrez, Maricarmen Rojas-López, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 1, 1995
Strongyloidiasis in patients with hematologic malignanciesM Nucci, R Portugal, W Pulcheri, et al.
Journal of Medicinal Chemistry|February 3, 2006
Synthesis of thieno[2,3-b]pyridinones acting as cytoprotectants and as inhibitors of [3H]glycine binding to the N-methyl-D-aspartate (NMDA) receptorHans-Peter Buchstaller, Carsten D Siebert, Ralf Steinmetz, et al.
Neuroscience Letters|December 8, 2009
Blood-brain barrier cell line PBMEC/C1-2 possesses functionally active P-glycoproteinWinfried Neuhaus, Martina Stessl, Elisabeth Strizsik, et al.
Pageof 12

Showing results (81-90 of 111) with videos related to

Sort By:
Pageof 12
Nucleic Acids Research|November 11, 1991
A simple procedure for the preparation of protected 2'-O-methyl or 2'-O-ethyl ribonucleoside-3'-O-phosphoramiditesE Wagner, B Oberhauser, A Holzner, et al.
Nucleic Acids Research|May 25, 1991
2'-O-methyl, 2'-O-ethyl oligoribonucleotides and phosphorothioate oligodeoxyribonucleotides as inhibitors of the in vitro U7 snRNP-dependent mRNA processing eventM Cotten, B Oberhauser, H Brunar, et al.
Plos One|January 28, 2014
Transport rankings of non-steroidal antiinflammatory drugs across blood-brain barrier in vitro modelsIveta Novakova, Eva-Anne Subileau, Stefan Toegel, et al.
Chirality|January 1, 1994
Improved synthesis and pharmacologic activity of the enantiomers of a new benzofurane type antiarrhythmic compoundG Ecker, W Fleischhacker, T Helml, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|June 26, 1999
Evaluation of aminoalkylmethacrylate nanoparticles as colloidal drug carrier systems. Part I: Synthesis of monomers, dependence of the physical properties on the polymerization methodsH P Zobel, A Zimmer, S Atmaca-Abdel Aziz, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|September 8, 1999
Evaluation of aminoalkylmethacrylate nanoparticles as colloidal drug carrier systems. Part II: characterization of antisense oligonucleotides loaded copolymer nanoparticlesH P Zobel, F Stieneker, S Atmaca-Abdel Aziz, et al.
The Journal of Infectious Diseases|March 13, 2015
Proteolytic Cleavage of the Plasmodium falciparum Circumsporozoite Protein Is a Target of Protective AntibodiesDiego A Espinosa, Gabriel M Gutierrez, Maricarmen Rojas-López, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 1, 1995
Strongyloidiasis in patients with hematologic malignanciesM Nucci, R Portugal, W Pulcheri, et al.
Journal of Medicinal Chemistry|February 3, 2006
Synthesis of thieno[2,3-b]pyridinones acting as cytoprotectants and as inhibitors of [3H]glycine binding to the N-methyl-D-aspartate (NMDA) receptorHans-Peter Buchstaller, Carsten D Siebert, Ralf Steinmetz, et al.
Neuroscience Letters|December 8, 2009
Blood-brain barrier cell line PBMEC/C1-2 possesses functionally active P-glycoproteinWinfried Neuhaus, Martina Stessl, Elisabeth Strizsik, et al.
Pageof 12